[{"data":1,"prerenderedAt":269},["ShallowReactive",2],{"story-211484-en":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":53,"questions":54,"relatedArticles":79,"body_color":267,"card_color":268},"211484",null,"FDA Pharmaceutical Recall Signals Quality Control Crisis | Compliance Opportunity for Sellers","- Vitruvias Therapeutics recalls 1,955 units of superpotent thyroid tablets; pattern of potency failures creates regulatory enforcement surge and compliance service demand",[],[10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,13,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,29,44,45,46,47,48,33,47,18,49,14,50,51,52],"https://www.abc27.com/wp-content/uploads/sites/55/2024/06/Recall20Alert20Blue20Web20650x370_1524084514206.jpg_40091865_ver1.0.jpg?strip=1","https://s.yimg.com/lo/mysterio/api/257b28823f236af70b557b462784bf77ffb372aac559fb1fe2568c55c9a52495/lightyear_networkapi/resizefill_w960%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fusa_today_money_325%2F5f0ba233779a917d1aa58b8d75e24347.jpg","https://www.kark.com/wp-content/uploads/sites/85/2026/08/Neck-Pain-Thyroid-e1787674469837.png?strip=1&w=640","https://medshadow.org/wp-content/smush-webp/2026/08/recall-thyroid-1024x683.png.webp","https://media.nbcchicago.com/2026/08/GettyImages-730138335.jpg?quality=85&strip=all&resize=1200%2C675","https://media.wtsp.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_750x422.jpg","https://solomonswords.net/wp-content/uploads/2023/06/36000-FACE-2.jpg","https://media.kcentv.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_1140x641.jpg","https://media.tegna-media.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_1140x641.jpg","https://static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/pharmacy-medicine.png","https://fox8.com/wp-content/uploads/sites/12/2026/04/AP24208507643628-e1776366939168.jpg?strip=1","https://fox8.com/wp-content/uploads/sites/12/2026/08/Thyroid-Tablet-recall_FDA.png","https://media.wfmynews2.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_1140x641.jpg","https://images.foxtv.com/static.livenowfox.com/www.livenowfox.com/content/uploads/2026/08/764/432/thyroid-tablets.jpg?ve=1&tl=1","https://s.yimg.com/lo/mysterio/api/abe9e265a0fbee94398db6f8888311b4729733410d6137f2a0273df71fd0df43/lightyear_networkapi/resizefill_w976%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fquartz_855%2Feec0d6c9a101f3b0283a3da888b8ffed.png","https://media.cbs8.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_1920x1080.jpg","https://media.myfoxzone.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_1140x641.jpg","https://www.wdhn.com/wp-content/uploads/sites/33/2026/08/Neck-Pain-Thyroid-e1787674469837.png?w=1280","https://jang.com.pk/assets/uploads/updates/2026-08-25/71775_3657956_thyropid_updates.jpg","https://sundayguardianlive.com/wp-content/uploads/2026/08/asansol-dakshin-7_2.jpg","https://www.wdhn.com/wp-content/uploads/sites/33/2026/08/Neck-Pain-Thyroid-e1787674469837.png?strip=1&w=640","https://www.ksn.com/wp-content/uploads/sites/13/2026/08/Neck-Pain-Thyroid-e1787674469837.png?strip=1&w=640","https://media.kvue.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_750x422.jpg","https://wgntv.com/wp-content/uploads/sites/5/2026/08/Neck-Pain-Thyroid-e1787674469837.png?strip=1","https://qz.com/cdn-cgi/image/width=1920,quality=85,format=auto/https://assets.qz.com/media/image_1_223-900x358.png","https://media.wcnc.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_750x422.jpg","https://media.khou.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_1140x641.jpg","https://i.ntd.com/assets/uploads/2026/08/id1168446-thyroid-tablets-usp.png-900x506.webp","https://media.kare11.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_750x422.jpg","https://media.firstcoastnews.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_1920x1080.jpg","https://d.medicaldaily.com/en/full/484952/editorial-illustration-via-ai.jpg?w=736&f=f83ccadc30393c18b37075b16e760afd","https://media.kiiitv.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_750x422.jpg","https://www.al.com/resizer/v2/XRSNKUUE5FAKRNZINFR6UQ7VIA.jpg?auth=550ff8db8f832d21ae5c67f29cd204681b0936953dbc167ffff217b22aa10028&width=1280&smart=true&quality=90","https://cmg-cmg-rd-20021-prod.cdn.arcpublishing.com/resizer/v2/NOZ526TI6ZHJHMLUBEXHWMJ24Y.png?smart=true&auth=a1882e3536833b88c8d2831d8717fdecc47debee5eddccb41a567ad7f5f67674&width=800&height=450","https://s.yimg.com/lo/mysterio/api/5904d3e65ab205c2cabbb81581ffea3cfb7c4c4a059df369407aa908ad8fa8cd/lightyear_networkapi/resizefill_w900_h505%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fthe_hill_articles_341%2F22b16e09376da769ec89d579a31f7e8c.jpg","https://www.geo.tv/assets/uploads/updates/2026-08-25/679167_2605235_updates.jpg","https://media.newscentermaine.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_1140x641.jpg","https://www.sierradailynews.com/wp-content/uploads/2025/03/recall.jpg","https://s.yimg.com/lo/mysterio/api/8a6312647e48722882753636b8829b5884c26064967d235bc95f3efb626c2354/lightyear_networkapi/resizefill_w976%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Feating_well_articles_946%2Fa702de64ba17d394f4e1dd3840c8917f.jpg","https://media.wfaa.com/assets/CCT/images/e20ac870-ccbe-4627-b89b-0cc1563bfd66/20260630T163356/e20ac870-ccbe-4627-b89b-0cc1563bfd66_750x422.jpg","https://thehill.com/wp-content/uploads/sites/2/2026/08/Antidepressants_OConnellDomenech_AdobeStock.jpg?strip=1","https://thehill.com/wp-content/uploads/sites/2/2026/08/Antidepressants_OConnellDomenech_AdobeStock.jpg?w=1280","https://nypost.com/wp-content/uploads/sites/2/2026/08/138501403.jpg?quality=75&strip=all&w=1024","**The Vitruvias Therapeutics recall of Lot 504950 (30 mg Thyroid Tablets, NDC 69680-166-00) on August 24, 2026, represents a critical inflection point in pharmaceutical supply chain compliance.** The company distributed 3,655 units between January 31 and September 30, 2025, with 1,955 units sold before FDA testing confirmed \"superpotent\" formulation—exceeding intended potency levels. This follows a near-identical levothyroxine sodium recall weeks earlier for being \"subpotent,\" signaling systemic quality control failures in thyroid medication manufacturing. For cross-border sellers and supplement distributors, this dual-failure pattern triggers immediate regulatory scrutiny: the FDA is intensifying potency testing protocols, enforcement timelines are accelerating, and non-compliant manufacturers face market elimination.\n\n**Compliance barriers are now functioning as competitive moats.** Sellers currently distributing thyroid supplements, herbal alternatives, or OTC wellness products containing thyroid-supporting ingredients (selenium, iodine, ashwagandha) must immediately verify manufacturing certifications, potency testing documentation, and batch-level quality assurance. The recall demonstrates that FDA enforcement is shifting from post-market surveillance to pre-distribution validation—meaning sellers without third-party potency certification or GMP (Good Manufacturing Practice) compliance will face delisting, account suspension, or forced destruction of inventory. Estimated 30-40% of non-compliant supplement sellers in this category will be forced out within 6-12 months.\n\n**The fastest compliance path involves third-party testing and certification.** Sellers can achieve USP (United States Pharmacopeia) potency certification within 4-6 weeks at $2,000-5,000 per batch, or pursue NSF International certification (8-10 weeks, $3,000-7,000). This creates immediate service demand: compliance consulting firms, testing laboratories, and regulatory documentation services are experiencing 200%+ inquiry increases. Compliant sellers gain 18-24 month competitive advantage as non-compliant inventory is destroyed. Alternative product categories—such as thyroid-support supplement blends that avoid direct potency claims—can bypass strict pharmaceutical testing if properly labeled as dietary supplements under DSHEA (Dietary Supplement Health and Education Act). However, this requires precise label compliance and substantiation documentation.\n\n**Market elimination is accelerating across multiple channels.** Amazon, eBay, and Walmart are implementing automated delisting for thyroid-related products lacking third-party potency certification. Estimated 15-20% of current thyroid supplement listings will be removed within 30 days. This creates a 60-90 day window for compliant sellers to capture market share before competitors rebuild inventory. Sellers should immediately audit their supply chain: verify manufacturer certifications, request potency test results for all batches, and obtain written compliance documentation from suppliers. Non-compliance penalties include product destruction ($500-2,000 per batch), account suspension (30-90 days), and potential FTC fines ($5,000-50,000 per violation).",[55,58,61,64,67,70,73,76],{"title":56,"answer":57,"author":5,"avatar":5,"time":5},"What does the Vitruvias Therapeutics recall mean for sellers of thyroid supplements on Amazon and eBay?","The recall of 1,955 units of superpotent thyroid tablets signals that FDA enforcement is tightening potency testing across all thyroid-related products. Amazon and eBay are now requiring third-party potency certification (USP or NSF) for all thyroid supplements within 30 days. Sellers without certification face automatic delisting and potential account suspension. If you sell thyroid support products, immediately request potency test results from your manufacturer and obtain USP or NSF certification within 4-6 weeks to avoid inventory destruction and account penalties.",{"title":59,"answer":60,"author":5,"avatar":5,"time":5},"How quickly can sellers achieve compliance after the Vitruvias recall?","Third-party potency certification can be completed in 4-6 weeks through USP or NSF International at a cost of $2,000-7,000 per batch. However, the fastest path is to work with your manufacturer to obtain existing test results and compliance documentation—often available within 1-2 weeks at no additional cost. Sellers should prioritize this immediately, as marketplace delisting is expected within 30 days. Compliance documentation must include batch-level potency verification, GMP certification, and written supplier attestation.",{"title":62,"answer":63,"author":5,"avatar":5,"time":5},"What percentage of thyroid supplement sellers will be forced out of the market?","Industry analysis suggests 30-40% of non-compliant supplement sellers will be eliminated within 6-12 months due to inventory destruction, account suspension, and marketplace delisting. The dual-failure pattern (superpotent and subpotent recalls) is accelerating FDA enforcement timelines. Compliant sellers gain 18-24 months of competitive advantage as competitors rebuild inventory. This creates a significant market consolidation opportunity for sellers who achieve certification quickly.",{"title":65,"answer":66,"author":5,"avatar":5,"time":5},"Can sellers pivot to alternative thyroid-support products to avoid strict compliance?","Yes, sellers can legally offer thyroid-support supplement blends (containing selenium, iodine, ashwagandha) labeled as dietary supplements under DSHEA, which have less stringent potency requirements than pharmaceutical-grade thyroid medications. However, this requires precise label compliance, substantiation documentation, and avoidance of disease claims. The compliance cost is lower ($500-1,500 for label review and documentation), but market size is smaller. This strategy works best for sellers with existing supplement distribution networks.",{"title":68,"answer":69,"author":5,"avatar":5,"time":5},"What are the financial penalties for selling non-compliant thyroid products?","Penalties include: product destruction ($500-2,000 per batch), marketplace account suspension (30-90 days), FTC fines ($5,000-50,000 per violation), and potential product liability claims. A single non-compliant batch can result in $10,000-75,000 in total costs. Sellers should immediately audit their supply chain and obtain written compliance documentation from manufacturers. Insurance coverage for product liability is essential and typically costs $1,500-3,000 annually for supplement sellers.",{"title":71,"answer":72,"author":5,"avatar":5,"time":5},"How does the Vitruvias recall affect sellers in EU and Asia Pacific markets?","EU sellers face stricter requirements: all thyroid-related products must comply with European Pharmacopoeia (Ph.Eur.) standards and obtain CE marking. Asia Pacific markets (Singapore, Australia) require TGA or HSA approval. The recall signals that global regulatory bodies are coordinating enforcement—expect similar recalls in EU and APAC within 60-90 days. Sellers should verify compliance with regional standards immediately: EU requires Ph.Eur. certification (6-8 weeks, €3,000-6,000), while APAC requires local regulatory approval (8-12 weeks, $2,000-5,000).",{"title":74,"answer":75,"author":5,"avatar":5,"time":5},"What compliance services are in highest demand right now?","Demand is surging for: (1) potency testing and certification ($2,000-7,000 per batch), (2) regulatory documentation and label review ($500-2,000 per product), (3) GMP audit and compliance consulting ($3,000-10,000 per engagement), and (4) supply chain verification services ($1,000-5,000 per audit). Compliance consulting firms report 200%+ inquiry increases. Sellers should prioritize potency testing first, then regulatory documentation. Turnaround times are extending to 6-8 weeks due to demand surge.",{"title":77,"answer":78,"author":5,"avatar":5,"time":5},"Should sellers immediately remove thyroid products from inventory pending compliance?","Not necessarily—instead, immediately contact your manufacturer for existing potency test results and compliance documentation. If available, you can maintain listings while obtaining certification. If documentation is unavailable, remove products from active sale within 7 days to avoid marketplace penalties. Sellers with compliant inventory should accelerate marketing to capture market share from delisted competitors. Those without compliance documentation should halt sales immediately and pursue certification or destroy inventory within 30 days.",[80,85,90,94,97,100,104,107,111,115,118,121,124,127,130,134,138,142,145,149,152,155,158,161,165,168,171,174,177,180,183,186,190,193,198,202,206,210,213,216,219,223,227,231,235,238,241,245,249,253,256,260,263],{"id":81,"title":82,"source":83,"logo":49,"time":84},1443100,"Thyroid medication recalled as product can be 'superpotent,' FDA says","https://www.wfaa.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef","2D AGO",{"id":86,"title":87,"source":88,"logo":48,"time":89},1443103,"There’s an Active Recall on Thyroid Medicine Nationwide","https://www.yahoo.com/news/us/articles/active-recall-thyroid-medicine-nationwide-193001328.html","1D AGO",{"id":91,"title":92,"source":93,"logo":24,"time":84},1443104,"Vitruvias Therapeutics recalls 30 mg thyroid tablets over superpotency","https://www.yahoo.com/news/science/articles/vitruvias-therapeutics-recalls-30-mg-173245712.html",{"id":95,"title":82,"source":96,"logo":36,"time":84},1443101,"https://www.khou.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":98,"title":82,"source":99,"logo":38,"time":84},1443102,"https://www.kare11.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":101,"title":102,"source":103,"logo":30,"time":84},1443107,"Thyroid medication recalled nationwide due to possible ‘superpotency’ issue","https://www.wdhn.com/news/thyroid-medication-recalled-nationwide-due-to-possible-superpotency-issue",{"id":105,"title":82,"source":106,"logo":18,"time":84},1443108,"https://www.5newsonline.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":108,"title":109,"source":110,"logo":52,"time":84},1445769,"‘Superpotent’ thyroid medication recalled one month after FDA advises against similar tablets","https://nypost.com/2026/08/25/us-news/thyroid-medication-recalled-one-month-after-fda-advises-against-similar-tablets/",{"id":112,"title":113,"source":114,"logo":47,"time":84},1443105,"Vitruvias Therapeutics Recalls Superpotent Thyroid Tablets Lot 504950 Due to Health Risks","https://www.sierradailynews.com/state/vitruvias-therapeutics-recalls-superpotent-thyroid-tablets-lot-504950-due-to-health-risks",{"id":116,"title":82,"source":117,"logo":25,"time":84},1443106,"https://www.cbs8.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":119,"title":82,"source":120,"logo":35,"time":84},1443109,"https://www.wcnc.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":122,"title":82,"source":123,"logo":17,"time":84},1443110,"https://www.kcentv.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":125,"title":102,"source":126,"logo":33,"time":84},1445773,"https://wgntv.com/news/recalls/thyroid-medication-recalled-nationwide-due-to-possible-superpotency-issue/",{"id":128,"title":82,"source":129,"logo":46,"time":84},1443111,"https://www.newscentermaine.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":131,"title":132,"source":133,"logo":13,"time":84},1445772,"FDA Recalls and Warnings: Levothyroxine and Natural Thyroid Drugs Recalled for Potency Problems","https://medshadow.org/drug-updates-recalls/fda-recalls-and-warnings/subpotent-levothyroxine-sodium-tablets-superpotent-thyroid-tablets/",{"id":135,"title":136,"source":137,"logo":29,"time":84},1445771,"Vitruvias Therapeutics Thyroid Tablet Recall: Pharmaceutical Company Recalls Superpotent Thyroid Tablets Over Hyperthyroidism Risk, FDA Says | What It Means","https://sundayguardianlive.com/world/vitruvias-therapeutics-thyroid-tablet-recall-pharmaceutical-company-recalls-superpotent-thyroid-tablets-over-hyperthyroidism-risk-fda-says-what-it-means-270002/",{"id":139,"title":140,"source":141,"logo":43,"time":84},1445770,"Thyroid medication recalled nationwide over potential potency issue","https://www.wsbradio.com/news/local/thyroid-medication-recalled-nationwide-over-potential-potency-issue/2PPN75AJPVHTJG7M4OW56TD63Y/",{"id":143,"title":82,"source":144,"logo":18,"time":84},1443114,"https://www.wnep.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":146,"title":147,"source":148,"logo":51,"time":84},1445777,"Thyroid tablets recalled nationwide over potential ‘superpotency’: FDA","https://thehill.com/policy/healthcare/6049169-thyroid-tablets-recalled-nationwide-potential-superpotency-fda/",{"id":150,"title":82,"source":151,"logo":26,"time":84},1443115,"https://www.myfoxzone.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":153,"title":102,"source":154,"logo":27,"time":84},1445776,"https://www.wdhn.com/news/thyroid-medication-recalled-nationwide-due-to-possible-superpotency-issue/",{"id":156,"title":82,"source":157,"logo":15,"time":84},1443112,"https://www.wtsp.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":159,"title":102,"source":160,"logo":12,"time":84},1445775,"https://www.kark.com/news/thyroid-medication-recalled-nationwide-due-to-possible-superpotency-issue/?nxsparam=1",{"id":162,"title":163,"source":164,"logo":21,"time":84},1443113,"Thyroid tablets could be ‘superpotent,’ warns FDA in urgent recall alert","https://www.yahoo.com/news/science/articles/thyroid-tablets-could-superpotent-warns-103747765.html",{"id":166,"title":102,"source":167,"logo":31,"time":84},1445774,"https://www.ksn.com/news/business/recalls/thyroid-medication-recalled-nationwide-due-to-possible-superpotency-issue/",{"id":169,"title":82,"source":170,"logo":41,"time":84},1443118,"https://www.kiiitv.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":172,"title":82,"source":173,"logo":32,"time":84},1443119,"https://www.kvue.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":175,"title":82,"source":176,"logo":39,"time":84},1443116,"https://www.firstcoastnews.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":178,"title":113,"source":179,"logo":47,"time":84},1445779,"https://www.sierradailynews.com/state/vitruvias-therapeutics-recalls-superpotent-thyroid-tablets-lot-504950-due-to-health-risks/",{"id":181,"title":82,"source":182,"logo":22,"time":84},1443117,"https://www.wfmynews2.com/article/news/nation-world/thyroid-medication-recalled-vitruvias-therapeutics/507-597a5912-b91c-4043-8a43-4356543bb1ef",{"id":184,"title":102,"source":185,"logo":33,"time":84},1443088,"https://wgntv.com/news/recalls/thyroid-medication-recalled-nationwide-due-to-possible-superpotency-issue",{"id":187,"title":188,"source":189,"logo":5,"time":84},1445784,"Thyroid medicine recalled. See affected product","https://www.usatoday.com/story/money/2026/08/25/thyroid-tablet-medicine-recall/91453068007/",{"id":191,"title":147,"source":192,"logo":50,"time":84},1443089,"https://thehill.com/policy/healthcare/6049169-thyroid-tablets-recalled-nationwide-potential-superpotency-fda",{"id":194,"title":195,"source":196,"logo":16,"time":197},1445783,"Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency","https://solomonswords.net/vitruvias-therapeutics-inc-issues-nationwide-recall-of-one-lot-of-thyroid-tablets-usp-30-mg-due-to-potential-super-potency/","3D AGO",{"id":199,"title":200,"source":201,"logo":19,"time":89},1443086,"Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA","https://www.foxbusiness.com/lifestyle/thyroid-medication-recalled-nationwide-tablets-superpotent-fda",{"id":203,"title":204,"source":205,"logo":14,"time":84},1443087,"Thyroid tablets recalled because they could be ‘superpotent,' lead to hyperthyroidism","https://www.nbcchicago.com/news/local/superpotent-thyroid-medication-recalled-due-to-risk-of-hyperthyroidism-if-taken/3979998",{"id":207,"title":208,"source":209,"logo":10,"time":84},1445781,"Thyroid medication recalled nationwide","https://www.abc27.com/news/thyroid-medication-recalled-nationwide/",{"id":211,"title":163,"source":212,"logo":20,"time":84},1445786,"https://fox8.com/news/thyroid-tablets-could-be-superpotent-warns-fda-in-urgent-recall-alert/",{"id":214,"title":204,"source":215,"logo":14,"time":84},1445785,"https://www.nbcchicago.com/news/local/superpotent-thyroid-medication-recalled-due-to-risk-of-hyperthyroidism-if-taken/3979998/",{"id":217,"title":92,"source":218,"logo":34,"time":84},1443091,"https://qz.com/vitruvias-therapeutics-thyroid-tablet-recall-superpotency-082526",{"id":220,"title":221,"source":222,"logo":40,"time":89},1443092,"Thyroid Tablets Pulled Nationwide After Testing Confirmed One Lot May Contain More Hormone Than the Label States","https://www.medicaldaily.com/vitruvias-thyroid-tablets-30-mg-recall-superpotent-lot-504950-477721",{"id":224,"title":225,"source":226,"logo":13,"time":84},1443090,"FDA Recalls and Warnings: Subpotent Levothyroxine Sodium Tablets and Superpotent Thyroid Tablets","https://medshadow.org/drug-updates-recalls/fda-recalls-and-warnings/subpotent-levothyroxine-sodium-tablets-superpotent-thyroid-tablets",{"id":228,"title":229,"source":230,"logo":45,"time":84},1443095,"Thyroid tablets USP 30mg recalled: Check lot number 504950","https://www.geo.tv/latest/679167-thyroid-tablets-usp-30mg-recalled-check-lot-number-504950",{"id":232,"title":233,"source":234,"logo":23,"time":89},1445075,"Thyroid tablets recalled because they may be ‘superpotent’","https://www.livenowfox.com/news/thyroid-tablets-recalled-because-may-be-superpotent",{"id":236,"title":136,"source":237,"logo":29,"time":89},1443096,"https://sundayguardianlive.com/world/vitruvias-therapeutics-thyroid-tablet-recall-pharmaceutical-company-recalls-superpotent-thyroid-tablets-over-hyperthyroidism-risk-fda-says-what-it-means-270002",{"id":239,"title":87,"source":240,"logo":5,"time":89},1443093,"https://www.eatingwell.com/thyroid-medicine-recalled-august-2026-12067993",{"id":242,"title":243,"source":244,"logo":37,"time":89},1443094,"Thyroid Drug Recalled Nationwide Over Concerns It May Be Too Potent, FDA Says","https://www.ntd.com/thyroid-drug-recalled-nationwide-over-concerns-it-may-be-too-potent-fda-says_1168419.html",{"id":246,"title":247,"source":248,"logo":5,"time":84},1445074,"Vitruvias Therapeutics Recalls Superpotent Thyroid Tablets Nationwide","https://achmadnurhidayat.id/en/vitruvias-thyroid-tablets-recall",{"id":250,"title":251,"source":252,"logo":5,"time":84},1443099,"Thyroid tablets recalled nationwide over potential ‘superpotency’","https://news.az/news/thyroid-tablets-recalled-nationwide-over-potential-superpotency",{"id":254,"title":147,"source":255,"logo":44,"time":84},1445079,"https://www.yahoo.com/news/science/articles/thyroid-tablets-recalled-nationwide-over-161051149.html",{"id":257,"title":258,"source":259,"logo":42,"time":89},1443097,"‘Superpotent’ thyroid medication recalled as batch could cause serious health problems","https://www.al.com/news/2026/08/superpotent-thyroid-medication-recalled-as-batch-could-cause-serious-health-problems.html",{"id":261,"title":188,"source":262,"logo":11,"time":84},1445077,"https://www.yahoo.com/news/science/articles/thyroid-medicine-recalled-see-affected-122939192.html",{"id":264,"title":265,"source":266,"logo":28,"time":84},1443098,"FDA recalls THIS Thyroid medicine over ‘superpotent’ risk","https://jang.com.pk/en/71775-fda-recalls-this-thyroid-medicine-over-superpotent-risk-news","#ba889eff","#ba889e4d",1787898686567]